PRXI - ETF AI Analysis
Top Page
Praxis Impact International ETF (PRXI)
Rating:64Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered positive year-to-date returns, showing it has held up reasonably well so far this year.
Leading Global Companies in Top Holdings
Several of the largest positions, such as ASML, Mitsubishi UFJ Financial Group, HSBC, and Siemens, have shown strong performance, helping support the fund’s overall results.
Broad International Diversification
The fund spreads its investments across many countries including Japan, the UK, Germany, France, the U.S., and others, which helps reduce the impact of weakness in any single market.
Negative Factors
Moderately High Expense Ratio
The ETF’s expense ratio is on the higher side for a passive fund, which means more of the return is eaten up by fees over time.
Mixed Performance Among Top Holdings
Some key holdings like Nestlé, SAP, and Toyota have been weak this year, which can drag on the fund’s overall performance.
Recent Short-Term Weakness
The ETF has shown negative performance over the past month, suggesting it can be sensitive to short-term market swings.
PRXI vs. SPDR S&P 500 ETF (SPY)
AUM6.86M
RegionDeveloped Markets
Expense Ratio0.54%
Beta0.66
IssuerPraxis
Inception DateJun 24, 2026
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume3,410
30 Day Avg. Volume2,124
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
29.69Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering293
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PRXI Summary
Praxis Impact International ETF (PRXI) is an actively managed fund that invests in companies from developed countries outside North America, following a broad international stock market theme with a faith-based, values-driven approach. It holds well-known global names like Nestlé, Toyota, ASML, and HSBC, and spreads investments across many regions such as Japan, the UK, and Europe, and across sectors like financials, healthcare, and consumer goods. Someone might invest in PRXI to gain international diversification while aligning their money with their religious or ethical values. A key risk is that international stocks can go up and down with global markets and currency changes.
How much will it cost me?This ETF has an expense ratio of 0.54%, which means you’ll pay about $5.40 per year for every $1,000 you invest. That’s higher than the average low-cost index ETF because PRXI is actively managed and uses a specialized, faith-based impact investing approach.
What would affect this ETF?This ETF focuses on developed markets outside the U.S., so it could benefit if Europe and Japan see stronger economic growth, stable politics, and supportive central bank policies, especially for its large positions in technology, health care, and major global banks like HSBC and Mitsubishi UFJ. On the other hand, slower growth abroad, rising interest rates that hurt financials, currency swings versus the U.S. dollar, or new regulations and controversies that affect its faith-based screening or key holdings such as ASML, Roche, and Nestlé could weigh on future returns.
PRXI Top 10 Holdings
PRXI leans on a handful of global heavyweights to do the heavy lifting, with ASML and Siemens acting as key growth engines despite some recent choppiness, thanks to strong long-term momentum in tech and industrial innovation. Japanese financial giant Mitsubishi UFJ and HSBC are rising and give the fund a solid banking backbone, while Nestlé has been losing a bit of steam and modestly weighs on returns. Overall, the ETF is broadly diversified across sectors and countries, but tilts toward European and Japanese blue chips rather than any single high-flying theme.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.33% | $227.39K | €581.61B | 86.21% | 76 Outperform | |
| HSBC Holdings | 1.77% | $121.00K | £259.22B | 45.81% | 80 Outperform | |
| Mitsubishi UFJ Financial Group | 1.68% | $114.68K | ¥41.53T | 40.32% | 76 Outperform | |
| Roche Holding AG | 1.61% | $109.60K | $346.33B | 37.61% | 73 Outperform | |
| Novartis AG | 1.46% | $99.46K | CHF219.30B | 22.56% | 80 Outperform | |
| AstraZeneca | 1.36% | $92.94K | $257.92B | 12.66% | 80 Outperform | |
| Toyota Motor | 1.31% | $89.69K | ¥35.40T | 0.67% | 80 Outperform | |
| Nestlé SA | 1.27% | $86.79K | CHF198.50B | 0.76% | 71 Outperform | |
| Siemens | 1.23% | $84.08K | €212.14B | 22.94% | 74 Outperform | |
| SAP SE | 1.11% | $75.62K | €217.07B | -18.31% | 66 Neutral |
PRXI Technical Analysis
Negative
―
Price Trends
25.53
Negative
Market Momentum
-0.14
Positive
41.49
Neutral
23.06
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For PRXI, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 25.47, equal to the 50-day MA of 25.53, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.14 indicates Positive momentum. The RSI at 41.49 is Neutral, neither overbought nor oversold. The STOCH value of 23.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PRXI.
PRXI Peer Comparison
Comparison Results
Performance Comparison
PRXI
Praxis Impact International ETF
25.02
0.47
1.91%
RWIN
Rayliant NxtGen Multifactor International Equity ETF
―
―
―
FFDI
Fidelity Fundamental Developed International ETF
―
―
―
JINT
Janus Henderson International Core Alpha ETF
―
―
―
TXUG
Thornburg International Growth Fund ETF
―
―
―
FHIL
Federated Hermes International Leaders ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents